Arctic Bioscience – Mandatory notification of trade

Ronja Capital AS, a legal person closely associated with a person discharging managerial responsibility in Arctic Bioscience, has today transferred 3,087,999 shares in Arctic Bioscience to Ronja Capital Investment AS at an average price of NOK 13,50 per share. Both companies are controlled by Roger Halsebakk and closely related to board member Tore Tønseth in Arctic Bioscience AS.

After the transaction Ronja Capital AS holds 0 shares and Ronja Capital Investment AS holds 3,087,999 shares in Arctic Bioscience AS, corresponding to an ownership of 12.17 % of the issued and outstanding share capital in Arctic Bioscience AS.

The transaction is related to internal restructuring of Ronja Capital AS.

Member of the Board of Directors, Tore A. Tønseth, is Investment Director at Ronja Capital AS.

Please refer to the attached notification of trading for further details. 

This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 and the Norwegian Securities Trading Act § 5-12.